Rate of remission after radio-ablative iodine therapy for thyrotoxicosis: The University Kebangsaan Malaysia Medical Centre (UKMMC) experience
2014
Objectives: To describe the rate of remission of thyrotoxicosis after radioablative
iodine-131 (RAI) therapy.
Methods: This was a retrospective review of 84 thyrotoxic patients who
received RAI in the year 2011/2012. Their blood investigations prior and
post-RAI therapy were reviewed. Data were analyzed using SPSS 19.
Results: Eighty-four patient received RAI therapy in 2011/2012 and was
followed-up till March 2014. The mean age of the patients was 45.8 ± 12.8
years. Majority (57.1%) received 12 mCi, 19% received 15 mCi and 23.8%
received lower dose (10 mCi) of RAI. Mean thyroxine level prior to RAI was
28.3 ± 12.0 pmol/L, and majority (77.8%) had suppressed TSH (<0.01
mIU/L) and 22.2% had low but detectable TSH (0.01-0.3 mIU/L). Fourtyfive
percent (44.9%) remained hyperthyroid at 6 months post RAI (44.2%
have suppressed TSH, 55.8% have detectable low TSH). Among those
who went into remission at 6 months, 31.6% were euthyroid and 68.4%
were hypothyroid. At 12 months 51.2% of patient goes into remission
where 39.5% of them were euthyroid and 60.5% were hypothyroid. Half
of the patient went into remission by 5 months post RAI therapy. By 24
months, 81.9% had gone into remission.
Conclusions: The percentage of remission after RAI therapy at our centre
increases with duration. By 24 months RAI induces remission in about 82%
of patients
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI